Eterna Biologics Ltd
15567990
Some Concerns
- Negative net worth (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 18/04/2026
Due 02/05/2027
Industry
Officers
director · Since 16/03/2024
RESEARCHER
BRITISH · UNITED KINGDOM · Age 38
Also on 1 other board
director · Since 16/03/2024
RESEARCHER
INDONESIAN · UNITED KINGDOM · Age 32
Also on 1 other board
Persons with Significant Control
Tatjana Sauka Spengler
French · United States · Age 55
3rd Floor, 1 Ashley Road, Altrincham, WA14 2DT
Notified 16/03/2024
Dr. Daniel Mark Fountain
British · United Kingdom · Age 38
3rd Floor, 1 Ashley Road, Altrincham, WA14 2DT
Notified 16/03/2024
Dr Muhammad Hanifi
Indonesian · United Kingdom · Age 32
3rd Floor, 1 Ashley Road, Altrincham, WA14 2DT
Notified 16/03/2024
CompanyRankvs 2777+ SIC 72110 peers24
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
Company’s operational runway. The successful completion of these fundraising activities represents a material uncertainty that may cast significant doubt on Eterna Biologics’ ability to continue as a going concern. Nevertheless, taking into account the progress of current funding discussions, historical success in securing external support, and the Company's ability to adapt expenditure as require
Key FinancialsYear ending 31/03/2025
Net Worth
-£144k
Balance sheet strength
Cash
£48k
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
£56k
Current Liabilities
£38k
Debtors
£8k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.48 | +£0 |
| 2025 | 1.48 | — |
Derived from filed accounts. Not audited figures.